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The fusion of yeast vacuoles, like other organelles, requires a Rab-family guanosine triphosphatase (Ypt7p), a Rab effector
and Sec1/Munc18 (SM) complex termed HOPS (homotypic fusion and vacuole protein sorting), and soluble N-ethylma-
leimide-sensitive factor attachment protein receptors (SNAREs). The central 0-layer of the four bundled vacuolar SNAREs
requires the wild-type three glutaminyl (Q) and one arginyl (R) residues for optimal fusion. Alterations of this layer
dramatically increase the Km value for SNAREs to assemble trans-SNARE complexes and to fuse. We now find that added
purified HOPS complex strongly suppresses the fusion of vacuoles bearing 0-layer alterations, but it has little effect on
the fusion of vacuoles with wild-type SNAREs. HOPS proofreads at two levels, inhibiting the formation of trans-SNARE
complexes with altered 0-layers and suppressing the ability of these mismatched 0-layer trans-SNARE complexes to
support membrane fusion. HOPS proofreading also extends to other parts of the SNARE complex, because it suppresses
the fusion of trans-SNARE complexes formed without the N-terminal Phox homology domain of Vam7p (Qc). Unlike
some other SM proteins, HOPS proofreading does not require the Vam3p (Qa) N-terminal domain. HOPS thus proofreads
SNARE domain and N-terminal domain structures and regulates the fusion capacity of trans-SNARE complexes, only
allowing full function for wild-type SNARE configurations. This is the most direct evidence to date that HOPS is directly
involved in the fusion event.
INTRODUCTION
Proteins are routed to their correct intracellular compart-
ment by selective sorting into budding vesicles, targeting of
these vesicles to their proper organelle, and regulated mem-
brane fusion. Fusion entails successive steps of tethering;
enrichment of key proteins and lipids to form a fusion-
competent membrane microdomain (Lang et al., 2001; Wang
et al., 2002; Fratti et al., 2004); assembly of proteins from each
apposed membrane into fusion complexes; and lipid bilayer
rearrangements, often via a hemifusion intermediate. Intra-
cellular membrane fusion requires Rab family guanosine
triphosphatases (GTPases), multisubunit Rab-effector com-
plexes, Sec1/Munc18 (SM) proteins, and soluble N-ethylma-
leimide-sensitive factor attachment protein receptors (SNAREs)
(Jahn et al., 2003). Rab GTPases promote tethering and the
enrichment of proteins and lipids in microdomains that
support fusion (Lang et al., 2001; Miaczynska and Zerial,
2002; Wang et al., 2002). Rab-effector complexes bind to the
active, GTP-bound form of the Rabs and are thereby acti-
vated to further the fusion cascade. SM proteins associate
with SNAREs and are required for the ensuing membrane
fusion (Rizo and Südhof, 2002). Model studies, using
SNARE proteins reconstituted into liposomes (Weber et al.,
1998) or organelles bearing different levels of SNARE pro-
teins (Starai et al., 2007), have shown that complexes of
membrane-anchored SNAREs alone can promote either fu-
sion with preservation of vesicular integrity and mixing of
lumenal compartments (Nickel et al., 1999), membrane lysis
(Dennison et al., 2006; Chen et al., 2006), or both (Starai et al.,
2007). In contrast, fusion is accompanied by very little lysis
when it occurs with physiological levels of SNAREs, Rab
GTPase, and Rab effector (Starai et al., 2007). We are only
beginning to see how SNAREs promote fusion or lysis, what
regulates their function and directs it toward fusion, and
how this is coordinated with Rabs, their effectors, and SM
proteins.
SNARE proteins are recognized by their characteristic
heptad-repeat “SNARE motifs” which assemble into four-
helical coiled coils to form a SNARE complex (Fasshauer et
al., 1998). Structural studies (Sutton et al., 1998) have shown
that most of the amino acyl residues that face each other on
the apposed surfaces of the four helices in a SNARE complex
are apolar, with the notable exception of the clustered cen-
tral residues of each SNARE domain, termed the 0-layer. In
virtually all organisms and organelles, the 0-layer consists of
three glutaminyl and one arginyl residues, forming an ionic
core of the SNARE complex (Fasshauer et al., 1998). Genetic,
physiological, and biochemical studies have established the
importance of the 0-layer, although it remains unclear why
it is required.
SM family proteins are required for the SNARE-depen-
dent fusion of biological membranes (Toonen and Verhage,
2003; Burgoyne and Morgan, 2007). SM proteins interact
with SNARE proteins in at least three different modes.
Munc18-1 binds to the “closed” conformation of syntaxin,
thereby preventing its assembly into SNARE complexes
(Dulubova et al., 1999). Other SM proteins can bind to the
extreme N terminus of their cognate syntaxins without pre-
venting SNARE complex assembly (Dulubova et al., 2002;
Yamaguchi et al., 2002). SM proteins can also bind to a
preassembled SNARE complex and not the free syntaxin
(Carr et al., 1999; Scott et al., 2004). Elucidating the molecular
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mechanisms of SNARE-dependent membrane fusion will
require understanding the functional interactions between
SNAREs and SM family proteins during fusion.
Vacuoles (lysosomes) from Saccharomyces cerevisiae are
convenient for the study of SNARE-, SM protein-, and Rab
GTPase-dependent fusion. Vacuole homotypic fusion is re-
quired for normal organelle structure in vivo (Wada et al.,
1992), and it can be monitored conveniently in vitro by
colorimetric assays (Haas et al., 1994; Jun et al., 2007). When
purified vacuoles are incubated with ATP, their cis-SNARE
complexes are disassembled early in the incubation by the
combined action of Sec17p and Sec18p (Mayer et al., 1996;
Ungermann et al., 1998a; Jun and Wickner, 2007a). Tethering
requires the vacuolar Rab GTPase Ypt7p (Mayer and Wick-
ner, 1997) and its hexameric effector complex, termed HOPS
(homotypic fusion and vacuole protein sorting; Stroupe et al.,
2006). HOPS consists of a core of four subunits, Vps 11, 16,
18, and 33, associated on the vacuole with two other sub-
units, Vps39p and Vps41p (Sato et al., 2000; Seals et al., 2000).
After tethering, vacuoles are drawn against each other, es-
tablishing three microdomains: the disk-shaped boundary
domain of tightly apposed membrane from each vacuole;
the ring-shaped vertex domain at the edge of the boundary
domain; and the outside domain, which does not touch the
other vacuole (Wang et al., 2002). Each of the proteins (Wang
et al., 2002) and lipids (Fratti et al., 2004) that are required for
vacuole fusion become enriched at the vertex ring, and
fusion ensues. The vertex ring-enriched proteins (Ypt7p, HOPS,
SNAREs, and others) and lipids (phosphoinositides, ergosterol,
and diacylglycerol) are interdependent for their vertex en-
richment (Wang et al., 2003; Fratti et al., 2004). Studies with
reversible inhibitory ligands of these proteins and lipids
show that the formation of fusion-competent vertex ring
microdomains is reversible or highly cooperative (Jun et al.,
2006).
HOPS has a direct affinity for phosphoinositides and for
the Vam7p SNARE (Stroupe et al., 2006). The HOPS subunit
Vps39p has nucleotide exchange activity for Ypt7p (Wur-
mser et al., 2000), and HOPS binds specifically to the GTP-
bound form of Ypt7p (Seals et al., 2000). The HOPS subunit
Vps33p is a member of the SM protein family. Ypt7p and
HOPS are necessary for SNAREs to pair in trans (Collins and
Wickner, 2007). Vacuole fusion requires three glutaminyl
(Q)-SNAREs (Vti1p, Vam3p, and Vam7p) and one arginyl
(R)-SNARE (Nyv1p). Although the wild-type 3Q:1R set of
SNAREs gives optimal fusion, fusion can also occur in vitro
with 4Q SNAREs or even with 2Q SNAREs and 2R SNAREs
when complex assembly is driven by high concentrations of
SNAREs (Fratti et al., 2007). Vacuolar SNARE complexes are
associated with Sec17p (-SNAP) or HOPS, but not with
both (Collins et al., 2005). Although Sec17p association al-
lows SNARE complexes to be disassembled, the role of
HOPS association in SNARE complex function is unknown.
We now show that the addition of purified HOPS to
vacuole fusion reactions reduces the levels of noncanonical
trans-SNARE complexes formed during fusion, and further
reduces the capacity of these mismatched complexes to un-
dergo fusion. With wild-type 3Q:1R SNAREs, additional
HOPS stimulates trans-SNARE complex formation (Collins
and Wickner, 2007) and fusion. However, with 4Q SNAREs,
2Q:2R SNAREs, or 3Q:1R SNAREs in rotated positions in
the transcomplex, the addition of purified HOPS suppresses
the level of trans-SNARE complex and even further inhibits
the subsequent fusion. Furthermore, exogenous HOPS
strongly suppresses vacuole fusion when trans-SNARE com-
plexes include a mutant Vam7p SNARE lacking its phos-
phoinositide-binding Phox homology (PX) domain. Thus,
the HOPS association with SNARE complexes proofreads
the wild-type conformations of the trans-SNARE complex
and regulates its capacity to lead to membrane fusion.
MATERIALS AND METHODS
Yeast Strains, Vacuole Isolation, and In Vitro
Fusion Assay
Vacuoles were isolated by floatation on discontinuous Ficoll gradients (Haas et
al., 1994) from S. cerevisiae strains BJ3505 (MAT ura3-52 trp1-101 his3-200
lys2-801 gal2 (gal3) can1 prb1-1.6R pep4::HIS3) (Jones, 2002) and DKY6281
(MAT ura3-52 leu2-3112 trp1-901 his3-200 lys2-801 suc2-9 pho8::TRP1)
(Haas et al., 1994), or isogenic strains expressing Nyv1R192Qp (RFY1 and RFY2)
(Fratti et al., 2007). Unless otherwise stated, the in vitro vacuole fusion
reactions in this study were ATP-free fusion reactions (Thorngren et al., 2004),
incubated at 27°C for 90 min. These reactions contained 3 g of pep4
vacuoles (from BJ3505 derivatives) and 3 g of pho8 vacuoles (from
DKY6281 derivatives) in 20 mM piperazine-N,N-bis(2-ethanesulfonic acid)
(PIPES)-KOH, pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2, 10 M
CoA, 815 nM purified Pbi2p (IB2), and 10 mg/ml bovine serum albumin
(BSA). Mature Pho8p alkaline phosphatase activity was assayed as a measure
of vacuole fusion (Haas, 1995). Fusion units (U) are micromoles of p-nitro-
phenylate formed per minute per microgram of pep4 vacuole.
Reagents
Antibodies were purified as described previously, and they were dialyzed
into PS buffer (20 mM PIPES-KOH, pH 6.8, and 200 mM sorbitol) with 125
mM KCl. Anti-Vam3p (Wang et al., 2003) was used at 900 nM, and
affinity-purified anti-Sec17p (Haas and Wickner, 1996) was used at 209 nM.
Recombinant glutathione transferase (GST)-Vam7p, GST-Vam7Q283Rp, and
GST-Vam7-SD fusion proteins were purified via glutathione-affinity chro-
matography and dialyzed into PS containing 125 mM KCl (Fratti et al.,
2007; Fratti and Wickner, 2007).
HOPS Overproduction
A yeast strain producing a Vps33-TEV-GST fusion protein was constructed by
transforming BJ2168 (MAT ura3-52 leu2-3112 trp1-101 prb1-1122 pep4-3
prc1-407 gal2) (Zubenko et al., 1980) with a polymerase chain reaction (PCR)
product formed from a two-round PCR amplification. A GST-TRP1 PCR
product was amplified from pFA6a-GST-TRP1 (Longtine et al., 1998) by using
primers 1a and 1b (Table 1), introducing a tobacco etch virus (TEV) protease
site upstream of the GST coding region. This product was used as a template
in a second round of PCR with primers 1b and 1c. This PCR product was
transformed into BJ2168, directing the recombination of the -TEV-GST-TRP1
PCR product to the 3 end of VPS33. This strain was named CSY14.
The p400GAL1 series of vectors, based on the pRS400 vectors (Sikorski and
Hieter, 1989), were a generous gift from E. Schiebel (ZMBH, Heidelberg,
Germany). VPS33-TEV-GST was amplified from CSY14 chromosomal DNA
by using primer set 2 and cloned into the SpeI/SalI sites of p403GAL1. VPS18,
VPS11, and VPS16 were amplified from FY834 (MAT ura3-52 leu21
lys2202 trp163 his3200) (Winston et al., 1995) by using primer sets 3, 4, and
5, respectively. Each of these products was cloned into p405GAL1, p406GAL1,
and p404GAL1, respectively, by using the SpeI/XhoI, BamHI/XhoI, and
BamHI/XhoI sites.
To construct a strain expressing all six HOPS genes under the control of the
GAL1 promoter, FY834 was sequentially transformed with the following
linearized plasmids: p403GAL1-VPS33-TEV-GST digested with NsiI, p405GAL1-
VPS18 digested with StuI, p406GAL1-VPS11 digested with BstXI, and
p404GAL1-VPS16 digested with NdeI. The GAL1 promoter from pYM-N23
(Janke et al., 2004) was amplified with primer set 6, and it was targeted to
recombine upstream of VPS41 through flanking homologous DNA sequence
in each primer. The GAL1 promoter was amplified from pFA6a-kanMX6-
PGAL (Longtine et al., 1998) by using primer set 7, and it was targeted to
recombine upstream of VPS39 by extending the flanking VPS39 homology of
the initial PCR product with primer set 8. This created the strain CHY26,
which overproduced all of the HOPS subunits upon growth in the presence of
galactose.
A cassette from pAG32 (Goldstein and McCusker, 1999) was then used to
delete the PEP4 gene from CHY26 by using the PEP4 primer sequences used
in the commercial nonessential deletion library (Giaever et al., 2002), resulting
in CHY31 (CHY24 pep4::KanMX4).
GST-HOPS Purification
CHY31 from solid medium was grown at 30°C in CSM-his-leu-trp-ura drop-
out medium (MP Biomedicals, Irvine, CA), supplemented with yeast nitrogen
base, 0.1% monosodium glutamate, 2% glucose, 100 g/ml Clonat (WERNER
BioAgents, Jena, Germany), and 200 g/ml G418, adjusted to pH 6.5 with
KOH, for 14 h. This culture was used to inoculate 600 ml of the medium, and
growth was continued for 8 h, when OD600 reached 1.3. Four 6-l flasks, each
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with 2.5 l of YP  2% galactose, were inoculated with 160 ml each of the
starter culture and grown at 30°C for 14 h to OD600  1.5. Each flask then
received 130 ml of 50% glucose, and cells were grown for an additional 90 min
(final OD600  2.0). Cells were harvested by centrifugation (Beckman JA-10
rotor; 5000 rpm, 5 min, 23°C), resuspended with a glass rod, and mixed by
inversion in 100 mM Tris-Cl, pH 9.4, 10 mM dithiothreitol (50 ml/OD  l),
incubated with occasional inversion in a 30°C water bath for 10 min, and
centrifuged as described above. Each pellet was resuspended in 15 ml/OD 
l of 80% YP, 0.16% glucose, 0.6 M sorbitol, and 0.05 M KPi, pH 7.5, mixed with
2 mg of recombinant lyticase/OD  l, and incubated 35 min at 30°C, with
inversion every 10 min. Suspensions were transferred to six ice-cold JA-14
bottles and centrifuged (5000 rpm, 5 min, 2°C). Supernatants were aspirated,
and the pellet was gently resuspended in 1.1 the measured pellet weight of
ice-cold 15% Ficoll, 20 mM PIPES-KOH, pH 6.8, and 200 mM sorbitol. DEAE-
dextran (100 l/OD  l of a 25 mg/ml solution in 8% Ficoll [8% Ficoll (wt/vol),
20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol]) was used to resuspend the
pellets, which were incubated 2 min on ice with gentle mixing every 30 s,
placed at 30°C for 4 min, and then returned to ice. Cells were transferred to
ice-cold 60Ti ultracentrifuge tubes, 10 ml/tube, and mixed by inversion with
14 ml of 8% Ficoll [8% Ficoll (wt/vol), 20 mM PIPES-KOH, pH 6.8, and 200
mM sorbitol] before centrifugation (50,000 rpm, 65 min, 4°C). Floated vacu-
oles were collected, glycerol was added to 10%, phenylmethylsulfonyl fluo-
ride (PMSF) was added to 1 mM, and the suspension was added dropwise
directly to liquid nitrogen. The frozen droplets were stored at 80°C.
Frozen vacuoles (800 mg of protein) were thawed, mixed with 1.2 l of cold
20 mM HEPES-NaOH, pH 7.8, 200 mM sorbitol, and 50 mM NaCl, and
centrifuged (JA-14 rotor; 10,000 rpm, 15 min, 4°C). Pellets were suspended in
800 ml of HOPS vacuole lysis buffer (HVLB: 20 mM HEPES-NaOH, pH 7.8,
400 mM NaCl, 10% glycerol, 5 mM 2-mercaptoethanol, and 1.0% Triton X-100)
and incubated on ice for 20 min. Insoluble material was removed by centrif-
ugation (60Ti; 20 min, 50,000 rpm, 4°C), and the supernatant was passed
through a 0.2-m filter (Millipore, Billerica, MA). This was applied to a 2.5 
8 cm glutathione-Sepharose 4B column (GE Healthcare, Chalfont St. Giles,
United Kingdom), which had been pre-equilibrated with HVLB at 4°C. The
column was washed with 3 bed volumes of HVLB, and then 3 bed volumes
of low Triton X-100 HOPS buffer (LTHB: 20 mM HEPES-NaOH, pH 7.8, 400
mM NaCl, 10% glycerol, 5 mM 2-mercaptoethanol, and 0.004% Triton X-100).
Protein was eluted from the column with LTHB  10 mM glutathione.
Fractions containing HOPS were pooled, concentrated from 15 to 1 ml,
with a final protein concentration of 0.5–1.0 mg/ml in an Amicon Ultra-15
(100,000 NMWL; Millipore) centrifugal filter device, distributed into small
aliquots, and frozen in liquid nitrogen. When calculated, the molar concen-
trations of HOPS considered the molecular mass of HOPS to be 663 kDa,
assuming a 1:1:1:1:1:1 subunit stoichiometry in the complex.
RESULTS
We assay the fusion of vacuoles that have been purified from
two yeast strains. One lacks vacuolar lumenal proteases and
therefore accumulates inactive proalkaline phosphatase
(proPho8p), and the other has normal vacuole lumenal pro-
teases but is deleted for the gene encoding Pho8p. Although
neither vacuole population has phosphatase activity, bilayer
fusion and content mixing allow the proteases to gain access
to proPho8p and cleave it to active Pho8p. We measure
vacuole fusion and content mixing by a colorimetric assay of
this active Pho8p. The homotypic fusion of yeast vacuoles
normally depends upon the formation of 3Q:1R trans-
SNARE complexes (Fratti et al., 2007). Although vacuoles
with either 4Q or 2Q:2R SNARE complexes can fuse, fusion
requires either higher levels of SNAREs or the addition of
exogenous compounds that promote lipid rearrangements
(Fratti et al., 2007). Because the purified HOPS complex
interacts with both the Vam7p SNARE and with certain
lipids (Stroupe et al., 2006), we tested whether it might
restore full fusion to vacuoles with noncanonical 0-layer
residues.
HOPS Complex Inhibits Fusion of Vacuoles with a
Mismatched SNARE 0-Layer
Purified vacuoles have substantial levels of unpaired, mem-
brane-anchored Vam3p, Vti1p, and Nyv1p (Collins et al.,
2005). When Vam7p, a soluble SNARE, is provided exog-
enously, fusion does not require ATP-dependent cis-SNARE
complex disassembly (Thorngren et al., 2004; Figure 1A,
filled squares). Although HOPS is required for in vitro vac-
uole fusion (Seals et al., 2000; Stroupe et al., 2006), isolated
vacuoles bear sufficient HOPS for fusion (0.52 nM in the
fusion reaction; Stroupe et al., 2006), and supplementation
with purified HOPS complex at levels 30-fold over the en-
dogenous vacuolar levels (15.8 nM) has little effect on fusion
at any level of added Vam7p (Figure 1A, open squares).
High concentrations of recombinant Vam7Q283Rp, mutated
to change the 0-layer residue from Q to R, can drive fusion
as a component of a 2Q:2R SNARE complex (Figure 1A,
filled circles), as reported previously (Fratti et al., 2007).
Unlike wild-type 3Q:1R SNARE complex fusion, however,
exogenous HOPS addition caused a striking inhibition of the
Vam7Q283Rp-mediated 2Q:2R fusion (Figure 1A, open cir-
cles). The HOPS SM protein subunit Vps33p, when purified
from yeast cytosol, did not have proofreading activity under
these conditions, even when added at a higher molar level
than HOPS (data not shown). This suggests that the proof-
Table 1. Primer sets used in this study
Primer set Sequence (5 to 3)
1a GGT CCA GGT GAA AAT TTG TA TTT TCA AGG TGG TCC AGG TCG GAT CCC CGG GTT AAT TAA
1b GCA CAT TTG CAT ATA CAA AAA ATT AAC AAA TCT ATC ATA TAA TAA GAA TTC GAG CTC GTT TAA AC
1c GCC GAT GGC TTG ATC AAT GGC ACA AGG ATC ATG AAC TCT ATA TCT GGT CCA GGT GAA AAT TTG TAT
TTT C
2 GCG CGT CGA CTT ATC AAC GCG GAA CCA GAT CCG
GCG CAC TAG TAT GAA TAG ATT TTG GAA TAC TAAG
3 GCG CAC TAG TAT GAT AAA AAC ACG TAT AGA GGA AG
GCG CCT CGA GCT ATT CAT TCC ATT TGG CTA ATT C
4 GCGCGGATCCATGTCCCTGAGCTCCTGGAG
GCGCCTCGAGTTAAATAGTGATGTCAGAATAACTG
5 GCG CGG ATC CAT GAA AAA CCC TAG CTT CGA CTG
GCG CCT CGA GCT ATA TCC TGC TCA TAG TTT CAT TTG
6 GCA AAA TAA AAA AGC ATT TTA ACG AAG AGT ATA TAC CTA CTA TTA GAC ATT AAT GCG TAC GCT GCA
GGT CGA C
CGC CTG ATT GTT GAT CCA AAA CAG AAT CAT TCT GAT GAT TAT CTG TAG TCA TCG ATG AAT TCT CTG TCG
7 GAT CAG CAA AAA CCC TTC AAA ATA TCA ATT TAT ACC AAA AAT TAA GAA TTC GAG CTC GTT TAA AC
CGC AGT GAT ATC CGA TGA TTT CAG CGA GTG TAG CTT TTG AGC TCT TAA CAT TTT GAG ATC CGG GTT TT
8 CGG CTG TTC AAT TAT CTT TTC AAC CGG ACG GGT CTT ATA TTG ATC AGC AAA AAC CCT TCA AAA TAT C
CTT TGC TAA AAC TAA TTT TTG TGA CTG TTC AGT GGG CAA AAT CGC AGT GAT ATC CGA TGA TTTC
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reading activity of HOPS may not reflect Vps33p function
alone, although we have no independent assay to verify the
activity of the isolated Vps33p.
To determine whether the HOPS complex inhibition of
fusion is specific to vacuoles forming a 2Q:2R trans-SNARE
complex, or whether it is a more general proofreading ac-
tivity, we isolated vacuoles from strains expressing the vac-
uolar R-SNARE Nyv1p as a Q-SNARE (Nyv1R192Qp). The
addition of Vam7Q283Rp to these vacuoles restores the po-
tential to form a 3Q:1R SNARE complex, albeit with the
position of these residues rotated with respect to the four-
helical bundle, and this provided slightly greater fusion
stimulation than the addition of wild-type Q-SNARE Vam7p
which formed a 4Q SNARE complex (Fratti et al., 2007;
Figure 1B, compare filled circles with filled squares). Adding
HOPS complex suppressed the fusion of Nyv1R192Qp vacu-
oles supported by either Vam7p or Vam7Q283Rp (Figure 1B,
open symbols). Together, HOPS complex favors the fusion
activity of the wild type and properly oriented 3Q:1R
SNARE complexes over any 0-layer mismatched set tested.
Because these assays were performed in the absence of
ATP, which is normally present in the cell and in our in vitro
reactions, we also tested the ability of HOPS to proofread the
SNARE complex 0-layer in the presence of ATP. To render
these reactions dependent on added Vam7p, Sec18p/Sec17p
priming activity was blocked by -Sec17p antibody, as re-
ported and characterized previously (Thorngren et al., 2004).
Under these conditions, fusion driven by up to 50 nM wild-
type Vam7p is not affected by the addition of 3.8 or 11.2
nM HOPS, although some inhibition is seen at 33.2 nM
HOPS (Figure 2A). In contrast, the fusion activity of
Vam7Q283Rp is strongly reduced in a HOPS concentration-
dependent manner (Figure 2B), confirming the ability of
HOPS to gauge the status of the SNARE-complex 0-layer
before content mixing.
HOPS Does Not Inhibit Fusion by Promoting Lysis
Whereas wild-type levels of SNAREs, Ypt7p, and HOPS
support fusion without triggering lysis, increasing the num-
ber of trans-SNARE complexes raises the overall amount of
organelle rupture, leading to fusion inhibition (Starai et al.,
2007). Although levels of all four SNAREs must be elevated
to cause massive lysis, detectable lysis can be triggered on
wild-type vacuoles by the addition of recombinant Vam7p
(Starai et al., 2007). Added HOPS can increase the number of
trans-SNARE complexes formed during fusion (Collins and
Wickner, 2007), although this increase does not cause addi-
tional lysis with wild-type vacuoles (Starai et al., 2007). To
test whether 0-layer mismatch promotes lysis, and whether
HOPS inhibits the 2Q:2R fusion driven by Vam7Q283Rp by
redirecting docked vacuoles toward lysis, we assayed the
release of green fluorescent protein (GFP) from the vacuole
lumen during fusion.
Under ATP-free conditions, the addition of Vam7p drives
fusion (Figure 3, bar 5 vs. 7) as well as measurable lysis
(Figure 3, bars 4 vs. 8). The addition of HOPS complex does
not significantly affect this Vam7p-driven fusion or lysis
(Figure 3, bars 9 and 10), and a SNARE ligand, -Vam3p,
inhibits fusion and lysis to basal levels (Figure 3, bars 11 and
12). A higher concentration of Vam7p does not drive signif-
icantly more fusion or lysis (Figure 3, bars 13–16).
Vam7Q283Rp causes less fusion and lysis than the wild-type
protein when used at the same concentrations (Figure 3, bars
19 and 20 and bars 25 and 26), in accordance with the finding
that Vam7p must form functional transcomplexes to drive
the lysis of vacuoles (Starai et al., 2007). HOPS complex
inhibits the fusion caused by Vam7Q283Rp (Figure 3, bars 19
vs. 21 and 25 vs. 27), and it does not enhance Vam7Q283Rp-
dependent lysis (Figure 3, bars 20 vs. 22 and 26 vs. 28).
Therefore, HOPS complex does not inhibit the fusion of
mismatched trans-SNARE complexes through increased
membrane lysis, but rather through a 0-layer proofreading
mechanism.
HOPS Regulates the Assembly, and Function, of
trans-SNARE Complexes
In contrast to a previous report from our group (Fratti et al.,
2007)—but in agreement with other reports showing that
4Q-SNARE-mediated membrane fusion is well-tolerated
Figure 1. HOPS complex inhibits fusion when the SNARE 0-layer
is altered. Vacuoles from either BJ3505 and DKY6281 (A) or RFY1
and RFY2 (bearing Nyv1R192Qp) (B) were assayed for fusion under
standard ATP-free conditions (see Materials and Methods). Either
wild-type Vam7p (squares) or mutant Vam7Q283Rp (circles) was
added at the indicated concentrations, either in the absence (closed
symbols) or presence (open symbols) of 15.8 nM purified HOPS
complex. Results are the mean of three independent experiments 
SD.
Figure 2. HOPS complex proofreads the 0-layer in the presence of
ATP. Vacuoles were assayed for fusion in reactions where the
priming block by -Sec17p was bypassed by added Vam7p (Thorn-
gren et al., 2004). Reactions (30 l) contained vacuoles from BJ3505
and DKY6281 (3 g each) in 20 mM PIPES-KOH, pH 6.8, 200 mM
sorbitol, 150 mM KCl, 6 mM MgCl2, 10 M CoA, 1 mM ATP, 1
mg/ml creatine kinase, 29 mM creatine phosphate, 815 nM purified
IB2, and 209 nM affinity-purified -Sec17. After 5 min on ice, HOPS
and either Vam7p (A) or Vam7Q283Rp (B) was added at the indicated
concentrations. Fusion was measured after 90 min at 27°C. Fusion
data are from three independent reactions, standardized as a per-
centage of the maximum fusion signal obtained with each Vam7p
addition, which was 4.78  0.72 U (A) and 1.38  0.33 U (B), mean 
SD.
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(Ossig et al., 2000; Katz and Brennwald, 2000)—vacuoles
bearing Nyv1R192Qp fuse with 78% the yield of wild-type
vacuoles under our standard, ATP-containing fusion condi-
tions (Figure 4A, bars 1 vs. 2). Adding HOPS to wild-type
vacuoles does not significantly change this fusion (Figure
4A, bars 1 vs. 7), but strongly inhibits the 4Q:0R SNARE
complex-mediated fusion of Nyv1R192Qp vacuoles (Figure
4A, bars 2 vs. 8). These data show that HOPS is a potent
inhibitor of mismatched 0-layer fusion in a standard in vitro
fusion assay.
By taking advantage of an assay designed to test when
vacuoles become resistant to a given fusion inhibitor, we can
dissect the vacuole fusion reaction into “priming,” “dock-
ing,” and “content mixing” stages (Ungermann et al., 1998b).
Using this assay, we can compare the kinetics of HOPS-
mediated fusion inhibition to inhibition by reagents that act
at specific reaction stages. Vacuoles bearing Nyv1R192Qp
become resistant to HOPS addition well after resistance to
antibodies against Sec17p (Figure 4B, squares vs. triangles).
HOPS resistance mirrors the resistance curves of -Ypt7p
(inverted triangles) and -Vam3p (diamonds), and HOPS
acts before content mixing (ice, circles). These data suggest
that the inhibitory HOPS proofreading activity occurs after
priming (defined by Sec17p function), during the trans-
SNARE pairing/docking stage of vacuole fusion (defined by
Ypt7p and Vam3p functions), and before membrane fusion
and content mixing.
To test how HOPS may function at the trans-SNARE pair-
ing/docking stage, we have exploited a recently developed
assay of trans-SNARE complexes (Collins and Wickner,
2007) to directly measure the effects of added HOPS when
the 0-layer of trans-SNARE complexes are mismatched. Un-
der ATP-free conditions, the association of Nyv1p with
Vam3p in trans and the subsequent fusion require added
Vam7p (Table 2, lines 2 and 4). Adding HOPS does not
significantly change the fusion yield or trans-SNARE com-
plex formation (Table 2, line 5). Vam7Q283Rp forms fewer
2Q:2R transcomplexes compared with the wild-type 3Q:1R
complex, and fusion is similarly reduced (Table 2, line 6).
Added HOPS complex strongly reduces the amount of
Vam7Q283Rp-containing trans-SNARE complex formed (line
7). Surprisingly, even the measurable amount of trans-
SNARE complex formed with Vam7Q283Rp in the presence
of HOPS is unable to drive proportional fusion (line 7).
Together, these data suggest that HOPS is intimately in-
volved in both proofreading the formation of physiological
3Q:1R 0-layer trans-SNARE complexes and in regulating the
capacity of those few trans-SNARE complexes which do
assemble to support fusion.
Figure 3. HOPS does not promote fusion-
dependent lysis with altered 0-layer SNARE
complexes. Reactions (90 l) containing 9 g
each of vacuoles from a BJ3505 derivative
bearing lumenal soluble GFP (Starai et al.,
2007) and from DKY6281 were incubated at
27°C under ATP-free conditions (see Materials
and Methods) with the following modifica-
tions: BSA was used at 3 mg/ml, and reactions
contained 0.1 protease inhibitor cocktail (50
stock: 13 g/ml leupeptin, 25 mM 1,10-phenan-
throline, 25 g/ml pepstatin A, and 5 mM Pe-
fabloc SC). This concentration of protease inhib-
itor does not inhibit the proteolytic activation
of proPho8p during fusion. Where indicated,
HOPS was added to 15.8 nM. After 45 min,
reactions were gently mixed and placed on ice;
30 l was withdrawn to measure fusion (black
bars) via Pho8p activity, and 30 l was assayed
for vacuolar lysis (white bars) via centrifugation
(5200  g, 6 min, 4°C) and assay of GFP fluo-
rescence in pellets and supernatants, as de-
scribed previously (Starai et al., 2007).
Figure 4. HOPS proofreads after SNARE complex disassembly
and before content mixing. Vacuoles were assayed for fusion under
ATP-containing conditions (20 mM PIPES-KOH, pH 6.8, 200 mM
sorbitol, 150 mM KCl, 6 mM MgCl2, 10 M CoA, 1 mM ATP, 1
mg/ml creatine kinase, 29 mM creatine phosphate, and 815 nM
purified IB2). (A) Reactions (30 l) containing either BJ3505 and
DKY6281 (3 g each, black bars) or RFY1 and RFY2 (3 g each,
white bars) were measured for fusion after 90 min at 27°C. Where
indicated, HOPS was added to 20.1 nM. Results are mean  SD. (B)
Reactions (30 l) containing RFY1 and RFY2 vacuoles were incu-
bated at 27°C, and either the fusion inhibitors -Sec17p (209 nM;
squares), HOPS complex (20.1 nM; triangles), -Ypt7p (467 nM;
inverted triangles), or -Vam3p (900 nM; diamonds) was added to
the fusion reactions at 0-, 10-, 20-, 45-, 60-, and 90-min time points,
or the reactions were removed to ice (circles) at the same intervals.
After 90 min, the extent of fusion was measured and compared with
the fusion levels of an uninhibited fusion reaction after 90 min
(maximal fusion). Results are the mean  SD of three independent
experiments (maximal fusion was 5.32, 5.89, and 5.0 U). The first 45
min of the reaction is plotted for clarity.
V. J. Starai et al.
Molecular Biology of the Cell2504
HOPS Complex Can Proofread Other Features of the
SNARE Complex
SM proteins can bind their cognate syntaxins through a
conserved N-terminal “HABC” domain (Toonen and Ver-
hage, 2003; Burgoyne and Morgan, 2007). The N-terminal
domain of syntaxin 1 is essential for Munc18-1–mediated
SNARE complex activation in a reconstituted system (Shen
et al., 2007), and it has been reported that HOPS can associate
with the syntaxin orthologue Vam3p at its N terminus
(Laage and Ungermann, 2001). Therefore, we tested whether
the N-terminal domain of Vam3p is required for HOPS-
dependent SNARE complex 0-layer proofreading. Under
ATP-free conditions, vacuoles bearing Vam3p lacking its
N-terminal HABC domain (Vam3N, Laage and Unger-
mann, 2001) can fuse when 200 nM Vam7p is provided
(Figure 5, bar 4). Added HOPS slightly inhibits this fusion
(bar 5). Vam7Q283R protein also supports the fusion of
Vam3N vacuoles (Figure 5, bar 6), but this fusion is strongly
inhibited by the addition of exogenous HOPS (Figure 5, bar 7).
Thus, HOPS can proofread the SNARE complex 0-layer in the
absence of the N terminus of the Vam3p syntaxin.
HOPS has been shown to associate with Vam7p in solu-
tion via the Vam7p phosphoinositide-binding PX domain
(Stroupe et al., 2006). To test whether the HOPS proofreading
of vacuole SNARE complexes extends to the Vam7p PX
domain, we exploited the fact that the purified Vam7p
SNARE domain, which lacks the PX domain, can support
vacuole fusion in the absence of ATP (Fratti and Wickner,
2007). Vacuole fusion supported by up to 1 M full-length,
wild-type Vam7p is essentially unaffected by the addition of
purified HOPS (Figure 6, compare closed squares with open
squares). As reported previously, purified Vam7p SNARE
domain (Vam7-SD) supports fusion with a much higher Km
value compared with wild-type Vam7p (Fratti and Wickner,
2007; Figure 6, compare closed circles with closed squares).
Adding HOPS to reactions containing Vam7-SD causes a
striking inhibition of fusion (Figure 6, open circles), showing
that the HOPS proofreading activity also gauges features of the
SNARE complex in addition to the 0-layer and outside the
SNARE domain coiled coils.
DISCUSSION
SM family proteins perform two related functions, the proof-
reading of SNARE-dependent membrane fusion events and
Table 2. HOPS modulation of trans-SNARE complexes and fusion activity
Reaction conditiona Fusion (U) trans-SNARE complexb Fusion (U) trans-SNARE complex
1. ice 0.17  0.02 0.4  0.13 0.5  0.17
2. no additions 0.16  0.02 0.9  0.49 0.3  0.19
3. HOPS 0.16  0.02 0.5  0.08 0.3  0.05
4. 150 nM Vam7p 4.45  0.51 4.1  1.98 1.4  0.81
5. 150 nM Vam7p  HOPS 4.97  0.51 4.3  1.29 1.2  0.32
6. 150 nM Vam7Q283Rp 2.92  0.94 3.1  1.35 1.0  0.39
7. 150 nM Vam7Q283Rp  HOPS 0.62  0.06 1.3  0.18 0.5  0.12
ATP-free fusion reactions (11 scale) with vacuoles from strains BJ3505 nyv1 CBP-VAM3 (Collins and Wickner, 2007) and DKY6281 were
incubated with the indicated additions at 27°C for 45 min. Reactions were transferred to ice for 5 min, gently mixed, and a 30-l aliquot was
withdrawn to assay alkaline phosphatase activity as a measure of fusion. CBP-Vam3p affinity pull-downs were performed (Collins and
Wickner, 2007). Vacuoles were sedimented (12,000  g, 5 min, 4°C) and dissolved in ice-cold 600 l of solubilization buffer (20 mM Tris-Cl,
pH 7.5, 150 mM NaCl, 1 mM MgCl2, 0.5% NP-40 Alternative Calbiochem, San Diego, CA	, 10% glycerol, 0.46 g/ml leupeptin, 3.5 g/ml
pepstatin, 2.4 g/ml pefabloc-SC, and 1 mM PMSF). After 20 min at 4°C with nutation, insoluble material was removed by centrifugation
(16,000  g, 20 min, 4°C), and 500 l of each vacuole extract was mixed with 50 l of calmodulin agarose, which had been pre-equilibrated
with solubilization buffer containing 2 mM CaCl2. CaCl2 was added to the vacuolar extract to final concentration of 2 mM, and the suspension
was rocked for 16 h at 4°C. Beads were harvested by centrifugation (1400  g, 2 min, 4°C) and washed five times with 500 l of ice-cold
solubilization buffer, sedimenting beads after each wash as described. Bead-bound proteins were eluted with SDS-polyacrylamide gel
electrophoresis (PAGE) loading buffer containing 5 mM EGTA, incubated 5 min at 98°C, separated by SDS-PAGE electrophoresis, and
transferred to nitrocellulose. CBP-Vam3p and Nyv1p were detected by immunoblotting. Films were scanned with a computer-controlled
PowerLook 1100 scanner (UMAX) and VueScan software version 8.0.4 (Hamrick Software, Phoenix, AZ). Image files were digitized, and the
total pixels making up the CBP-Vam3p and Nyv1p bands were quantified using UN-SCAN-IT version 5.1 (Silk Scientific, Orem, UT).
Reported values are the mean  SD of three independent experiments.
a Standard ATP-free reactions (see Materials and Methods); HOPS added to a final concentration of 16.7 g/ml, where noted.
b Defined as (Nyv1p pixels/CBP  Vam3p pixels)  10.
Figure 5. HOPS does not require the N-terminal HABC domain of
Vam3p for 0-layer proofreading activity. Vacuoles from BJ3505 and
DKY6281 derivatives bearing Vam3p deleted for its conserved N-
terminal HABC domain (Vam3N; Laage and Ungermann, 2001)
were assayed for fusion under standard ATP-free conditions after
90 min at 27°C. Vam7p proteins were added at the indicated con-
centration, and HOPS was added to a final concentration of 25.0 nM.
Results are the mean  SD of five independent experiments.
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the activation of the SNARE complex for fusion (Peng and
Gallwitz, 2002; Scott et al., 2004; Shen et al., 2007). The
biochemical and genetic data regarding SM proteins clearly
point to an essential role, yet the molecular interactions
governing SM protein function at each distinct step are only
recently being elucidated. Our current study examines the
physical and functional relationship during homotypic vac-
uolar fusion between the HOPS complex, which includes
Vps33p, an SM protein, and the SNARE complex.
We find that HOPS plays a significant role in ensuring
correct trans-SNARE complex formation and function. Al-
terations in the buried 0-layer of the SNARE complex that
cause a non3Q:1R—or even a rotated 3Q:1R—structure are
significant enough to cause HOPS to inhibit assembly (Fig-
ure 1 and Table 2). Because these residues are not surface
exposed (Fasshauer et al., 1998; Sutton et al., 1998), HOPS
may sense a conformational change in the SNAREs resulting
from these seemingly slight changes in the 0-layer, due to a
dedicated and specific mode of binding to SNAREs, or the
assembled SNARE complex. Binding interactions are often
regulated by slight conformational differences, which are
necessary to ensure interaction specificity above the back-
ground of other similar biological structures (Savir and
Tlusty, 2007). In other studies (Shen et al., 2007), mutations in
residues adjacent to the 1 and 5 layers in the SNARE
motif, which are surface-exposed in the SNARE complex,
abolish Munc18-1–mediated stimulation of liposome lipid
mixing without abolishing the basal SNARE-mediated lipid
mixing. In contrast, added HOPS complex inhibits the fusion
activity of noncanonical 0-layer SNARE complexes which
otherwise have significant fusion activity (Figures 1–6). Al-
though the N terminus of Vam3p promotes HOPS recruit-
ment to the vacuole (Laage and Ungermann, 2001), the
0-layer proofreading activity does not require the N-termi-
nal HABC SM-protein binding domain of Vam3p (Figure 5),
and thus HOPS recognition of the assembled SNARE com-
plex is not simply focused on the Vam3p HABC domain.
HOPS strongly suppresses the fusion capacity of trans-
SNARE complexes lacking the Vam7p PX domain (Figure 6),
possibly reflecting the direct affinity of this PX domain for
HOPS (Stroupe et al., 2006). HOPS may use several modes of
binding to the assembled SNARE complex to regulate its
assembly (Jun et al., 2007b) and may continue to function as
part of the trans-SNARE complex during fusion. These re-
sults support the finding that Munc18-1 can bind to synaptic
SNARE complexes in the absence of the syntaxin N-terminal
HABC domain (Shen et al., 2007), and they are in accord with
another report describing multiple modes of SM protein:
SNARE complex binding for yeast Vps45p (Carpp et al.,
2006).
We have reported previously (Fratti et al., 2007; Fratti and
Wickner, 2007) that the Km value for wild-type Vam7p to
support vacuole fusion is far lower than the Km value for
either Vam7Q283Rp or Vam7-SD. This may be caused by the
proofreading function of the endogenous vacuolar HOPS.
Added Vam7Q283Rp or Vam7-SD, which exceeds the HOPS
proofreading capacity, may lead to fusion. Fusion, whether
supported by wild-type or 2Q:2R trans-SNARE complexes
(Fratti et al., 2007), is blocked by antibodies to the HOPS
subunit Vps33p. Because HOPS activity is required for the
formation of even mismatched trans-SNARE complexes and
for the resulting membrane fusion, it is likely that SNARE
complex proofreading and the support of fusion are distinct
HOPS activities, each essential for physiological vacuole
fusion.
SM proteins can bind to the closed conformation of free
syntaxins and prevent them from entering SNARE com-
plexes in solution (Pevsner et al., 1994; Dulubova et al., 1999;
Yang et al., 2000; Misura et al., 2000). Yeast Sly1p, when
prebound to the Golgi syntaxin Sed5p, can also prevent the
formation of soluble 2Q:2R SNARE complexes (Peng and
Gallwitz, 2002). However, without SNARE transmembrane
anchors, this study could not measure the effects of the
assembled 2Q:2R SNARE complexes or the SM protein on
membrane fusion. Peng and Gallwitz (2004) also found that
direct, high-affinity binding of Sly1p to Sed5p was, surpris-
ingly, not required for either protein’s activity in vivo. Fur-
thermore, mutant versions of Sly1p could bind a number of
nonsyntaxin SNAREs, suggesting that SM proteins could
potentially interact with each of the SNAREs involved in a
particular SNARE complex assembly pathway. How, then,
do SM proteins prevent non3Q:1R or noncognate SNARE
complexes from forming? Simple steric hindrance from a
prebound and specific SM:syntaxin complex may be respon-
sible, because each SM protein is well localized to an indi-
vidual subcellular compartment, and it cannot compensate
for the absence of another SM protein at another organelle
(Toonen and Verhage, 2003). In contrast, SM proteins may
enhance the stability of cognate SNARE complexes, thereby
increasing the chances of that SNARE complex causing a
fusion event. Vacuole SNAREs, like their neuronal counter-
parts, may initially form a fusion-incompetent, “open”
transcomplex that must be converted to the fusion-compe-
tent “closed” SNARE complex. HOPS and its SM subunit
Vps33p might prevent noncognate SNARE complexes from
progressing from the open to the closed state, whereas
SNAREs alone may freely assemble and disassemble with-
out the ability to cause fusion. It has also been proposed that
SM proteins can spatially segregate noncognate SNAREs
from the active sites of fusion, concentrating the correct
SNAREs and increasing the probability that appropriate
SNARE complexes will form (Bethani et al., 2007). In addi-
tion, the activity of Munc18-1 on the SNARE-dependent
lipid mixing of reconstituted proteoliposomes is only seen
with the cognate neuronal SNAREs, and not with other
SNAREs that can support a background lipid mixing rate in
this assay (Shen et al., 2007). This SM protein-mediated
proofreading of SNARE identity is distinct from the proof-
Figure 6. HOPS proofreads at least one domain outside of the
SNARE motif. Vacuoles from BJ3505 and DKY6281 were assayed for
fusion under standard ATP-free conditions after 90-min incubation
with either wild-type Vam7p (squares) or the Vam7p SNARE do-
main which lacks the PX domain (Vam7-SD, circles). Assays were
performed in the absence (closed symbols) or presence (open sym-
bols) of 20.1 nM purified HOPS complex. Results are the mean  SD
of three independent experiments.
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reading of the proper 0-layer and N-domain state of the
SNARE complex, which we present here.
In addition to proofreading the SNARE complex, HOPS
has tethering and Ypt7p/Rab GTPase nucleotide exchange
functions, each of which is also required for efficient mem-
brane fusion (Price et al., 2000; Seals et al., 2000; Wurmser et
al., 2000; Stroupe et al., 2006). It is unclear whether the
RabGTPase nucleotide exchange activity of HOPS is re-
quired for its proofreading activity, but neither normal vac-
uole fusion nor HOPS proofreading activity responds to
exogenous additions of GTP (data not shown). However, SM
proteins could link Rab GTPase and SNARE functions; a
direct interaction between Munc18-1 and Rab3A was re-
cently detected in bovine brain extracts, in accord with this
idea (Graham et al., 2008). Therefore, the proofreading or
fusion activities of SM proteins could be regulated by cog-
nate Rab GTPase proteins, although SM proteins and HOPS
can activate SNARE-dependent lipid mixing in reconstituted
systems that lack Rab GTPases (Scott et al., 2004; Shen et al.,
2007; Mima and Wickner, unpublished data).
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Rizo, J. (1999). A conformational switch in syntaxin during exocytosis: role of
munc18. EMBO J. 18, 4372–4382.
Dulubova, I., Yamaguchi, T., Gao, Y., Min, S. W., Huryeva, I., Südhof, T. C.,
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J. E. (1999). Content mixing and membrane integrity during membrane fusion
driven by pairing of isolated v-SNAREs and t-SNAREs. Proc. Natl. Acad. Sci.
USA 96, 12571–12576.
Ossig, R., Schmitt, H. D., de Groot, B., Riedel, D., Keränen, S., Ronne, H.,
Grubmüller, H., and Jahn, R. (2000). Exocytosis requires asymmetry in the
central layer of the SNARE complex. EMBO J. 19, 6000–6010.
Peng, R., and Gallwitz, D. (2002). Sly1 protein bound to Golgi syntaxin Sed5p
allows assembly and contributes to specificity of SNARE fusion complexes.
J. Cell Biol. 157, 645–655.
Peng, R., and Gallwitz, D. (2004). Multiple SNARE interactions of an SM
protein: Sed5p/Sly1p binding is dispensable for transport. EMBO J. 23, 3939–
3949.
HOPS Proofreads SNARE Complexes
Vol. 19, June 2008 2507
Pevsner, J., Hsu, S. C., Braun, J. E., Calakos, N., Ting, A. E., Bennett, M. K., and
Scheller, R. H. (1994). Specificity and regulation of a synaptic vesicle docking
complex. Neuron 13, 353–361.
Price, A., Seals, D., Wickner, W., and Ungermann, C. (2000). The docking
stage of yeast vacuole fusion requires the transfer of proteins from a cis-
SNARE complex to a Rab/Ypt protein. J. Cell Biol. 148, 1231–1238.
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